or Try an Advanced Search...

    Clinical Trial Product Stocks List

    Symbol Grade Name % Change
    BIIB D Biogen Idec Inc. 1.87
    HALO D Halozyme Therapeutics, Inc. 0.23
    HCM B Hutchison China MediTech Limited -2.10
    INCY D Incyte Corporation 1.26
    LGND D Ligand Pharmaceuticals Incorporated 2.18
    LBPH B Longboard Pharmaceuticals, Inc. -6.29
    SUPN D Supernus Pharmaceuticals, Inc. 1.85
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis

    Related ETFs - A few ETFs which own one or more of the above listed Clinical Trial Product stocks.

    Symbol Grade Name Weight
    PJP A PowerShares Dynamic Pharmaceuticals 11.18
    FBT D First Trust Amex Biotech Index Fund 10.33
    IBRN D iShares Neuroscience and Healthcare ETF 9.08
    BIS D ProShares UltraShort Nasdaq Biotechnology 9.05
    PBE C PowerShares Dynamic Biotech & Genome 7.93
    View all Clinical Trial Product ETFs...
    Compare ETFs
    Compare FBT to BIS Compare IBRN to BIS Compare PJP to IBRN

        Clinical Trial Product Stocks Recent News

        Date Stock Title
        May 3 LBPH Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
        May 3 LGND Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
        May 3 LGND Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
        May 3 HALO How Novo-Catalent Deal Affects Halozyme (HALO)?
        May 3 INCY Q1 2024 Insight Enterprises Inc Earnings Call
        May 2 LBPH Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
        May 2 LGND Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
        May 2 LGND Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
        May 2 LGND Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
        May 2 LGND Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
        May 2 BIIB Biogen Reports Progress on Corporate Responsibility Priorities
        May 1 INCY Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
        May 1 BIIB Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
        May 1 LBPH Starbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
        May 1 SUPN Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
        Apr 30 BIIB Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings
        Apr 30 BIIB Biogen: Don't Overthink This One
        Apr 30 INCY Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
        Apr 30 INCY Incyte Corporation (INCY) Q1 2024 Earnings Call Transcript
        Apr 30 INCY Incyte misses quarterly profit on weak sales of lead drug
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Biotechnology Solid Tumors Alzheimer's Disease Chemical Compounds Chronic Lymphocytic Leukemia Clinical Trial Clinical Trial Products Drug Discovery Epilepsy Lymphocytic Leukemia Monoclonal Antibodies Nasdaq 100 Neurology Organic Compounds Pain Pharmaceutical Psoriasis S&P 500 Amyotrophic Lateral Sclerosis
        Clinical Trial Product

        Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.

        Browse All Tags